lintuzumab-ac225
actinium
['actimab-a', 'solid tumor', 'mds']
actinium presents data demonstrating actimab-a's potential use against solid tumors by selectively depleting immunosuppressive mdscs, a key component of the tumor microenvironment, at #aacr23 $atnm 
No investment advice. Do your own DD Market is all about taking the shares from the weak holders& providing opportunities to those that have the stamina to hold